The ten-year rule and other breast implant myths, checked against the evidence

Every medical field accumulates folklore, and breast augmentation has accumulated more than most. Some of it is harmless. Some of it drives real decisions, from skipped screening appointments to surgeries booked for no clinical reason. What follows is a working list of the claims patients repeat most often in consultation rooms, each checked against the published literature, FDA guidance, and manufacturer documentation. A pattern emerges quickly: most implant myths overstate either the fragility of the device or the danger of it.

Myth one: implants must be replaced every ten years. This is the most persistent claim in the field, and it is not what the evidence or the regulators say. There is no scheduled expiration date on a breast implant. The FDA and the manufacturers describe implants as devices with a limited service life, which is different from a fixed one. Implants are replaced when there is a reason, such as rupture, capsular contracture, or the patient's own change of preference, not on an anniversary. The ten-year figure appears to have grown out of warranty windows and the honest statistical observation that the longer any implant is in place, the higher the cumulative chance that something eventually warrants surgery. Our reporting on implant longevity and replacement covers what long-term maintenance actually involves. The practical translation: budget for a future operation, but do not book one by the calendar.

Myth two: a silent silicone rupture is an emergency. A rupture in a modern silicone implant often produces no symptoms at all, because the cohesive gel largely stays where it is. That is precisely why the FDA recommends periodic ultrasound or MRI surveillance of silicone devices rather than relying on how the breast looks or feels. When a silent rupture is found, the standard response is a planned, elective replacement, not urgent surgery. None of this makes rupture trivial, and a confirmed rupture should be addressed with a surgeon rather than watched indefinitely, but the gap between an emergency and an appointment is worth stating plainly, because fear of catastrophic failure is a common and largely misplaced anxiety.

Myth three: implants cause breast cancer. Decades of large epidemiological studies have not found an increased risk of breast cancer in women with implants. The nuance that deserves accuracy rather than alarm is BIA-ALCL, a rare lymphoma of the immune system associated primarily with certain textured implant surfaces, which is a distinct disease from breast cancer and one reason follow-up and device awareness matter. The related myth, that implants make cancer screening impossible, was solved decades ago with displacement views, as our piece on mammograms after augmentation explains. Women with implants should keep the same screening calendar as women without them.

Myth four: flying, scuba diving, or airport scanners can burst an implant. Cabin pressure changes and security scanners exert nowhere near the forces required to damage a modern implant shell. Small studies that took saline implants to altitude and depth found minor, temporary gas bubble changes at extremes, not failures. The same goes for the gym legend that chest exercise dislodges implants: once the pocket has healed, ordinary training does not move a well-placed device, although lifters with submuscular implants may notice the animation effects described in our piece on implant plane.

Myth five: gummy bear implants cannot rupture. Highly cohesive gel holds its shape impressively in demonstrations, which has fed a belief that the firmest devices are indestructible. The shell of a form-stable implant can still breach, and because the gel stays put, that breach is even more likely to be silent. Cohesivity changes how a rupture behaves, not whether one can happen, which is why the surveillance imaging schedule applies to every silicone device, including the ones nicknamed for candy. The trade-offs of firmer gels are covered in our piece on cohesive gel and implant shapes.

Myth six: you cannot breastfeed with implants. The majority of women with implants who attempt breastfeeding succeed, because implants sit behind the gland or the muscle rather than inside the milk-producing tissue. Incision choice and individual anatomy matter at the margins, and the honest details are laid out in our reporting on breastfeeding after augmentation. The blanket claim, repeated with surprising confidence online, does not survive contact with the lactation literature.

How to treat the next claim you hear. Ask where it comes from. Claims that trace back to a regulator, a manufacturer's labeling, or a peer-reviewed series deserve weight. Claims that trace back to a forum post or a marketing page deserve a question mark. A surgeon worth trusting will happily explain the mechanism behind any statement they make, and the habit of asking for that mechanism, encouraged in our guide to questions to ask before augmentation, is the single best filter for folklore. Implants are neither fragile nor risk-free. They are engineered devices with known, measurable behaviors, and the measured version of the truth is almost always calmer than the myth.

Related reading: Breast implant safety: a clear-eyed look.